Ascentage Pharma Group International (AAPG)

CIK 2023311 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ascentage Pharma Group International.

Recent SEC filings

FiledFormAccession number
Nov 5, 20266-K0001213900-26-116155
Oct 28, 20266-K0001213900-26-113124
Oct 22, 20266-K0001213900-26-111727
Oct 21, 20266-K0001213900-26-111393
Oct 15, 20266-K0001213900-26-109623
Sep 29, 20266-K0001213900-26-104196
Sep 17, 20266-K0001213900-26-100763
Aug 20, 20266-K0001213900-26-091901
Aug 13, 20266-K0001213900-26-088773
Aug 5, 20266-K0001213900-26-085424
Aug 3, 20266-K0001213900-26-084247
Jul 27, 20266-K0001213900-26-081816
Jul 20, 2026F-3ASR0001213900-26-079362
Jul 20, 20266-K0001213900-26-079420
Jul 13, 20266-K0001213900-26-077607
Jun 30, 20266-K0001213900-26-073699
Jun 29, 202630001213900-26-073067
Jun 15, 20266-K0001213900-26-068502
Jun 12, 20266-K0001213900-26-067938
Jun 10, 20266-K0001213900-26-067328
Jun 1, 20266-K0001213900-26-063156
May 28, 20266-K0001213900-26-061791
May 28, 20266-K0001213900-26-062191
May 22, 20266-K0001213900-26-060305
May 22, 202640001213900-26-060632